LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 3.66 | 27.76 | 716 | 283 | 2.5218 | 1.6350 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 5.36 | 27.76 | 561 | 320 | 1.7512 | 1.3442 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 5.36 | 27.76 | 810 | 320 | 2.5284 | 1.6013 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.06 | 27.76 | 658 | 360 | 1.8278 | 1.3544 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.06 | 27.76 | 2 | 360 | 0.0056 | -0.5091 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.06 | 27.76 | 906 | 360 | 2.5167 | 1.5671 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 8.76 | 27.76 | 722 | 401 | 1.7999 | 1.3296 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 8.76 | 27.76 | 2 | 401 | 0.0050 | -0.4947 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 8.76 | 27.76 | 976 | 401 | 2.4330 | 1.5191 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.46 | 27.76 | 5 | 438 | 0.0114 | -0.3498 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.46 | 27.76 | 796 | 438 | 1.8147 | 1.3229 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.46 | 27.76 | 1077 | 438 | 2.4553 | 1.5061 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.17 | 27.76 | 9 | 489 | 0.0184 | -0.2382 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.17 | 27.76 | 840 | 489 | 1.7175 | 1.2792 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.17 | 27.76 | 9 | 489 | 0.0184 | -0.2382 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.17 | 27.76 | 1171 | 489 | 2.3943 | 1.4697 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 13.87 | 27.76 | 79 | 604 | 0.1306 | 0.2653 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 13.87 | 27.76 | 885 | 604 | 1.4635 | 1.1789 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 13.87 | 27.76 | 18 | 604 | 0.0298 | -0.0928 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 13.87 | 27.76 | 1242 | 604 | 2.0539 | 1.3515 | MN20160318_Q01 | K18 |